Neuroprotective Roles of Apelin-13 in Neurological Diseases

被引:0
|
作者
Yang Zhang
Weiwei Jiang
Wenjie Sun
Weiming Guo
Beibei Xia
Xiangru Shen
Mingyuan Fu
Teng Wan
Mei Yuan
机构
[1] University of South China,Department of Neurology, The Second Affiliated Hospital, Hengyang Medical School
[2] Huazhong University of Science and Technology Union Shenzhen Hospital,Department of Neurology
[3] The 6th Affiliated Hospital of Shenzhen University Health Science Center,Department of Sports Medicine
[4] Huazhong University of Science and Technology Union Shenzhen Hospital,Hengyang Medical College
[5] The 6th Affiliated Hospital of Shenzhen University Health Science Center,undefined
[6] University of South China,undefined
来源
Neurochemical Research | 2023年 / 48卷
关键词
Apelin-13; Neurological diseases; Neuroinflammation; Apoptosis; Neuroprotection;
D O I
暂无
中图分类号
学科分类号
摘要
Apelin is a natural ligand for the G protein-coupled receptor APJ, and the apelin/APJ system is widely distributed in vivo. Among the apelin family, apelin-13 is the major apelin isoform in the central nervous system and cardiovascular system, and is involved in the regulation of various physiopathological mechanisms such as apoptosis, neuroinflammation, angiogenesis, and oxidative stress. Apelin is currently being extensively studied in the nervous system, and apelin-13 has been shown to be associated with the onset and progression of a variety of neurological disorders, including stroke, neurodegenerative diseases, epilepsy, spinal cord injury (SCI), and psychiatric diseases. This study summarizes the pathophysiological roles of apelin-13 in the development and progression of neurological related diseases.
引用
收藏
页码:1648 / 1662
页数:14
相关论文
共 50 条
  • [21] The effect of apelin-13 on gastric ischemia/reperfusion injury: the roles of sensory nerves and vagus nerve
    Birsen, Ilknur
    Izgut-Uysal, V. Nimet
    Soylu, Hakan
    Ustunel, Ismail
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (05) : 282 - 295
  • [22] Evaluation of Apelin-13 levels in patients with diabetic nephropathy
    Gamze İçen
    Gülçin Dağlıoğlu
    Mehtap Evran
    International Urology and Nephrology, 2023, 55 : 345 - 353
  • [23] Evaluation of Apelin-13 levels in patients with diabetic nephropathy
    Icen, Gamze
    Daglioglu, Gulcin
    Evran, Mehtap
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (02) : 345 - 353
  • [24] Apelin-13 inhibits lipid accumulation in human hepatocytes
    Park, Soojin
    Huang, Jin
    Im, Dongsoon
    FASEB JOURNAL, 2017, 31
  • [25] Evaluation of serum apelin-13 and apelin-36 concentrations in preeclamptic pregnancies
    Gurlek, Beril
    Yilmaz, Adnan
    Durakoglugil, Murtaza E.
    Karakas, Sibel
    Kazaz, Ilknur M.
    Onal, Ozgur
    Satiroglu, Omer
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2020, 46 (01) : 58 - 65
  • [26] Apelin-13 enhances contextual fear extinction in rats
    Chen, Fang-Ling
    Li, Jie
    Wang, Bo
    Tian, Shao-Wen
    Long, Chen
    NEUROSCIENCE LETTERS, 2019, 712
  • [27] Apelin-13 treatment enhances the stability of atherosclerotic plaques
    Fraga-Silva, R. A.
    Seeman, H.
    Montecucco, F.
    Da Silva, A. R.
    Costa-Fraga, F. P.
    Anguenot, L.
    Mach, F. P.
    Santos, R. A. S.
    Stergiopulos, N.
    Da Silva, R. F.
    CARDIOVASCULAR RESEARCH, 2016, 111 : S107 - S107
  • [28] Can Apelin-13 be a new actor in control of obesity?
    Tekin, S.
    Erden, Y.
    Etem, E.
    Sandal, S.
    Colak, C.
    ACTA PHYSIOLOGICA, 2014, 211 : 137 - 138
  • [29] Impact of Apelin-13 on the Development of Coronary Artery Ectasia
    Sun, Xusen
    Zhang, Yufan
    Qi, Xin
    Wei, Liping
    ACTA CARDIOLOGICA SINICA, 2020, 36 (03) : 216 - 222
  • [30] Apelin-13 treatment enhances the stability of atherosclerotic plaques
    Fraga-Silva, Rodrigo A.
    Seeman, Hugo
    Montecucco, Fabrizio
    da Silva, Analina R.
    Burger, Fabienne
    Costa-Fraga, Fabiana P.
    Anguenot, Lea
    Mach, Francois
    dos Santos, Robson A. S.
    Stergiopulos, Nikolaos
    da Silva, Rafaela F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 (03)